Pancreatic Cancer Research

ResearcherAichi Medical UniversityActive in the last 2 years

Shingo Inaguma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8585-8900; OpenAlex author ID A5084388250. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. Co-author DOI 10.1002/cam4.70124↗
  2. DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer. Co-author DOI 10.1093/carcin/bgab017↗
  3. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. Co-author DOI 10.18632/oncotarget.4960↗
  4. GLI1 interferes with the DNA mismatch repair system in pancreatic cancer through BHLHE41-mediated suppression of MLH1. Co-author DOI 10.1158/0008-5472.can-13-2008↗
  5. GLI1 modulates EMT in pancreatic cancer--letter. Co-author DOI 10.1158/0008-5472.can-12-0379↗
  6. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Co-author DOI 10.1038/onc.2010.459↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoichi Matsuo · 2 shared papers, 2021–2024 · strength 0.32
  2. Hiroyuki Kato · 2 shared papers, 2021–2024 · strength 0.32
  3. Akihisa Kato · 2 shared papers, 2021–2024 · strength 0.32
  4. Satoru Takahashi · 2 shared papers, 2021–2024 · strength 0.32
  5. Makoto Sano · 1 shared paper, 2024 · strength 0.20
  6. Hideaki Ijichi · 1 shared paper, 2024 · strength 0.20
  7. Hiroshi Ikeda · 4 shared papers, 2011–2015 · strength 0.19
  8. Kenji Kasai · 4 shared papers, 2011–2015 · strength 0.19
  9. Kenta Kachi · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.